Comprehensive Stock Comparison

Compare CareTrust REIT, Inc. (CTRE) vs Ventas, Inc. (VTR) Stock

Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.

Tickers 2 / 10100+ Metrics

Selected Stocks

Add up to 10 tickers. Use presets or search to get started.

2 / 10
Try these comparisons:

Quick Verdict

CategoryWinnerWhy
GrowthCTRE108.7% revenue growth vs VTR's 18.5%
ValueCTRELower P/E (27.1x vs 114.3x)
Quality / MarginsCTRE80.6% net margin vs VTR's 4.3%
Stability / SafetyCTREBeta 0.17 vs VTR's 0.23
DividendsCTRE3.1% yield; 2-year raise streak; VTR pays no meaningful dividend
Momentum (1Y)CTRE+62.2% vs VTR's +27.3%
Efficiency (ROA)CTRE5.1% ROA vs VTR's 0.9%, ROIC 10.1% vs 2.5%
Bottom line: CTRE leads in 7 of 7 categories, making it the stronger pick for investors who prioritize growth and revenue expansion and valuation and capital efficiency. As direct sector peers, they can serve as alternatives in the same portfolio allocation.

Who Each Stock Is For

Income & stability

Growth exposure

Long-term compounding (10Y)

Sleep-well-at-night portfolio

Defensive / Recession hedge

Business Model

What each company does and how it makes money

CTRECareTrust REIT, Inc.
Real Estate

CareTrust REIT is a healthcare-focused real estate investment trust that owns and leases skilled nursing facilities, senior housing, and other medical properties across the United States. It generates revenue primarily through long-term triple-net leases—where tenants pay rent plus property expenses—with skilled nursing facilities representing its largest segment. The company's competitive advantage lies in its specialized healthcare real estate expertise and relationships with quality operators in a fragmented industry.

VTRVentas, Inc.
Real Estate

Ventas is a healthcare-focused real estate investment trust that owns and operates senior housing communities, medical office buildings, and life science research facilities. It generates revenue primarily through rental income from its diversified portfolio — roughly 60% from senior housing, 25% from medical office buildings, and 15% from life science and hospital properties. The company's competitive advantage lies in its scale, diversified healthcare property portfolio, and long-term relationships with leading healthcare operators across multiple care settings.

Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CTRECareTrust REIT, Inc.
FY 2025
Reportable Segment
100.0%$476M
VTRVentas, Inc.
FY 2025
Senior Living Operations
74.0%$4.3B
Outpatient Medical And Research Portfolio
15.5%$898M
Triple Net Leased Properties
10.4%$602M

Financial Metrics Comparison

Side-by-side fundamentals across 2 stocks. BestLagging

Financial Scorecard

CTRE 5VTR 0
Financial MetricsCTRE5/6 metrics
Valuation MetricsCTRE5/6 metrics
Profitability & EfficiencyCTRE7/8 metrics
Total ReturnsCTRE6/6 metrics
Risk & VolatilityTie1/2 metrics
Analyst OutlookCTRE1/1 metrics

CTRE leads in 5 of 6 categories — strongest in Financial Metrics and Valuation Metrics. 1 category is tied.

Financial Metrics (TTM)

VTR is the larger business by revenue, generating $5.6B annually — 17.1x CTRE's $324M. CTRE is the more profitable business, keeping 80.6% of every revenue dollar as net income compared to VTR's 4.3%. On growth, CTRE holds the edge at +82.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCTRECareTrust REIT, I…VTRVentas, Inc.
RevenueTrailing 12 months$324M$5.6B
EBITDAEarnings before interest/tax$262M$2.2B
Net IncomeAfter-tax profit$261M$238M
Free Cash FlowCash after capex$334M$1.2B
Gross MarginGross profit ÷ Revenue+96.6%+42.0%
Operating MarginEBIT ÷ Revenue+55.7%+14.7%
Net MarginNet income ÷ Revenue+80.6%+4.3%
FCF MarginFCF ÷ Revenue+103.2%+20.7%
Rev. Growth (YoY)Latest quarter vs prior year+82.4%+20.4%
EPS Growth (YoY)Latest quarter vs prior year+66.7%+2.1%
CTRE leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

At 25.9x trailing earnings, CTRE trades at a 84% valuation discount to VTR's 159.6x P/E. On an enterprise value basis, CTRE's 15.7x EV/EBITDA is more attractive than VTR's 24.1x.

MetricCTRECareTrust REIT, I…VTRVentas, Inc.
Market CapShares × price$9.0B$40.4B
Enterprise ValueMkt cap + debt − cash$8.8B$53.1B
Trailing P/EPrice ÷ TTM EPS25.87x159.56x
Forward P/EPrice ÷ next-FY EPS est.27.11x114.29x
PEG RatioP/E ÷ EPS growth rate1.22x
EV / EBITDAEnterprise value multiple15.72x24.07x
Price / SalesMarket cap ÷ Revenue18.99x6.93x
Price / BookPrice ÷ Book value/share2.05x3.08x
Price / FCFMarket cap ÷ FCF22.96x31.53x
CTRE leads this category, winning 5 of 6 comparable metrics.

Profitability & Efficiency

CTRE delivers a 6.5% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $2 for VTR. On the Piotroski fundamental quality scale (0–9), VTR scores 7/9 vs CTRE's 6/9, reflecting strong financial health.

MetricCTRECareTrust REIT, I…VTRVentas, Inc.
ROE (TTM)Return on equity+6.5%+1.9%
ROA (TTM)Return on assets+5.1%+0.9%
ROICReturn on invested capital+10.1%+2.5%
ROCEReturn on capital employed+11.0%+3.2%
Piotroski ScoreFundamental quality 0–967
Debt / EquityFinancial leverage1.04x
Net DebtTotal debt minus cash-$198M$12.6B
Cash & Equiv.Liquid assets$198M$786M
Total DebtShort + long-term debt$0$13.4B
Interest CoverageEBIT ÷ Interest expense10.76x1.35x
CTRE leads this category, winning 7 of 8 comparable metrics.

Total Returns (with DRIP)

A $10,000 investment in CTRE five years ago would be worth $20,333 today (with dividends reinvested), compared to $18,063 for VTR. Over the past 12 months, CTRE leads with a +62.2% total return vs VTR's +27.3%. The 3-year compound annual growth rate (CAGR) favors CTRE at 31.0% vs VTR's 23.5% — a key indicator of consistent wealth creation.

MetricCTRECareTrust REIT, I…VTRVentas, Inc.
YTD ReturnYear-to-date+11.9%+11.4%
1-Year ReturnPast 12 months+62.2%+27.3%
3-Year ReturnCumulative with dividends+124.9%+88.4%
5-Year ReturnCumulative with dividends+103.3%+80.6%
10-Year ReturnCumulative with dividends+343.7%+97.3%
CAGR (3Y)Annualised 3-year return+31.0%+23.5%
CTRE leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

CTRE is the less volatile stock with a 0.17 beta — it tends to amplify market swings less than VTR's 0.23 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.

MetricCTRECareTrust REIT, I…VTRVentas, Inc.
Beta (5Y)Sensitivity to S&P 5000.17x0.23x
52-Week HighHighest price in past year$41.72$87.87
52-Week LowLowest price in past year$25.48$60.15
% of 52W HighCurrent price vs 52-week peak+97.4%+98.1%
RSI (14)Momentum oscillator 0–10069.877.7
Avg Volume (50D)Average daily shares traded1.5M2.3M
Evenly matched — CTRE and VTR each lead in 1 of 2 comparable metrics.

Analyst Outlook

Wall Street rates CTRE as "Buy" and VTR as "Buy". Consensus price targets imply 3.7% upside for CTRE (target: $42) vs 2.9% for VTR (target: $89). CTRE is the only dividend payer here at 3.13% yield — a key consideration for income-focused portfolios.

MetricCTRECareTrust REIT, I…VTRVentas, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$42.11$88.70
# AnalystsCovering analysts1932
Dividend YieldAnnual dividend ÷ price+3.1%
Dividend StreakConsecutive years of raises20
Dividend / ShareAnnual DPS$1.27
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
CTRE leads this category, winning 1 of 1 comparable metric.

Historical Charts

Charts are rendered on first load. Hover for details.

Chart 1Total Return — 5 Years (Rebased to 100)

StockMar 20Feb 26Change
CareTrust REIT, Inc. (CTRE)100171.58+71.6%
Ventas, Inc. (VTR)100147.84+47.8%

CareTrust REIT, Inc. (CTRE) returned +103% over 5 years vs Ventas, Inc. (VTR)'s +81%. A $10,000 investment in CTRE 5 years ago would be worth $20,333 today (including dividends reinvested).

Chart 2Revenue Growth — 10 Years

Stock20162025Change
CareTrust REIT, Inc. (CTRE)$104M$476M+358.3%
Ventas, Inc. (VTR)$3.4B$5.8B+69.4%

CareTrust REIT, Inc.'s revenue grew from $104M (2016) to $476M (2025) — a 18.4% CAGR. Ventas, Inc.'s revenue grew from $3.4B (2016) to $5.8B (2025) — a 6.0% CAGR.

Chart 3Net Margin Trend — 10 Years

Stock20162025Change
CareTrust REIT, Inc. (CTRE)28.2%67.3%+138.3%
Ventas, Inc. (VTR)18.9%4.3%-77.1%

CareTrust REIT, Inc.'s net margin went from 28% (2016) to 67% (2025). Ventas, Inc.'s net margin went from 19% (2016) to 4% (2025).

Chart 4P/E Ratio History — 9 Years

Stock20172025Change
CareTrust REIT, Inc. (CTRE)46.623-50.6%
Ventas, Inc. (VTR)15.9143.3+801.3%

CareTrust REIT, Inc. has traded in a 23x–103x P/E range over 9 years; current trailing P/E is ~26x. Ventas, Inc. has traded in a 16x–393x P/E range over 7 years; current trailing P/E is ~160x.

Chart 5EPS Growth — 10 Years

Stock20162025Change
CareTrust REIT, Inc. (CTRE)0.521.57+201.9%
Ventas, Inc. (VTR)1.860.54-71.0%

CareTrust REIT, Inc.'s EPS grew from $0.52 (2016) to $1.57 (2025) — a 13% CAGR. Ventas, Inc.'s EPS grew from $1.86 (2016) to $0.54 (2025) — a -13% CAGR.

Chart 6Free Cash Flow — 5 Years

2021
$151M
$593M
2022
$137M
$666M
2023
$144M
$860M
2024
$236M
$726M
2025
$394M
$1B
CareTrust REIT, Inc. (CTRE)Ventas, Inc. (VTR)

CareTrust REIT, Inc. generated $394M FCF in 2025 (+161% vs 2021). Ventas, Inc. generated $1B FCF in 2025 (+116% vs 2021).

Loading custom metrics...

CTRE vs VTR: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is CTRE or VTR a better buy right now?

CareTrust REIT, Inc. (CTRE) offers the better valuation at 25.9x trailing P/E (27.1x forward), making it the more compelling value choice. Analysts rate CareTrust REIT, Inc. (CTRE) a "Buy" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CTRE or VTR?

On trailing P/E, CareTrust REIT, Inc. (CTRE) is the cheapest at 25.9x versus Ventas, Inc. at 159.6x. On forward P/E, CareTrust REIT, Inc. is actually cheaper at 27.1x.

03

Which is the better long-term investment — CTRE or VTR?

Over the past 5 years, CareTrust REIT, Inc. (CTRE) delivered a total return of +103.3%, compared to +80.6% for Ventas, Inc. (VTR). A $10,000 investment in CTRE five years ago would be worth approximately $20K today (assuming dividends reinvested). Over 10 years, the gap is even starker: CTRE returned +343.7% versus VTR's +97.3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CTRE or VTR?

By beta (market sensitivity over 5 years), CareTrust REIT, Inc. (CTRE) is the lower-risk stock at 0.17β versus Ventas, Inc.'s 0.23β — meaning VTR is approximately 38% more volatile than CTRE relative to the S&P 500.

05

Which has better profit margins — CTRE or VTR?

CareTrust REIT, Inc. (CTRE) is the more profitable company, earning 67.3% net margin versus 4.3% for Ventas, Inc. — meaning it keeps 67.3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTRE leads at 98.7% versus 14.2% for VTR. At the gross margin level — before operating expenses — CTRE leads at 98.9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is CTRE or VTR more undervalued right now?

On forward earnings alone, CareTrust REIT, Inc. (CTRE) trades at 27.1x forward P/E versus 114.3x for Ventas, Inc. — 87.2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CTRE: 3.7% to $42.11.

07

Which pays a better dividend — CTRE or VTR?

In this comparison, CTRE (3.1% yield) pays a dividend. VTR does not pay a meaningful dividend and should not be held primarily for income.

08

Is CTRE or VTR better for a retirement portfolio?

For long-horizon retirement investors, CareTrust REIT, Inc. (CTRE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.17), 3.1% yield, +343.7% 10Y return). Both have compounded well over 10 years (CTRE: +343.7%, VTR: +97.3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between CTRE and VTR?

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. In terms of investment character: CTRE is a small-cap income-oriented stock; VTR is a mid-cap quality compounder stock. CTRE pays a dividend while VTR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.

🚀
Stocks Like

CTRE

High-Growth Quality Leader

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 41%
  • Net Margin > 48%
Run This Screen
Stocks Like

VTR

High-Growth Disruptor

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 10%
  • Gross Margin > 25%
Run This Screen
Custom Screen

Better Than Both

Find stocks that beat CTRE and VTR on the metrics you choose

Revenue Growth>
%
(CTRE: 82.4% · VTR: 20.4%)
Net Margin>
%
(CTRE: 80.6% · VTR: 4.3%)
P/E Ratio<
x
(CTRE: 25.9x · VTR: 159.6x)